AASLD guidelines for treatment of chronic hepatitis B

doi:10.1002/hep.28156

. 2016 Jan;63(1):261-83.

doi: 10.1002/hep.28156. Epub 2015 Nov 13.

AASLD guidelines for treatment of chronic hepatitis B

Norah A Terrault¹, Natalie H Bzowej², Kyong-Mi Chang³, Jessica P Hwang⁴, Maureen M Jonas⁵, M Hassan Murad⁶; American Association for the Study of Liver Diseases

Affiliations

¹ University of California San Francisco, San Francisco, CA.
² Ochsner Medical Center, New Orleans, LA.
³ Corporal Michael J. Crescenz VA Medical Center & University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
⁴ The University of Texas MD Anderson Cancer Center, Houston, TX.
⁵ Boston Children's Hospital, Harvard Medical School, Boston, MA.
⁶ Mayo Clinic, Rochester, MN.

PMID: 26566064
PMCID: PMC5987259
DOI: 10.1002/hep.28156

AASLD guidelines for treatment of chronic hepatitis B

Norah A Terrault et al. Hepatology. 2016 Jan.

. 2016 Jan;63(1):261-83.

doi: 10.1002/hep.28156. Epub 2015 Nov 13.

Authors

Norah A Terrault¹, Natalie H Bzowej², Kyong-Mi Chang³, Jessica P Hwang⁴, Maureen M Jonas⁵, M Hassan Murad⁶; American Association for the Study of Liver Diseases

Affiliations

¹ University of California San Francisco, San Francisco, CA.
² Ochsner Medical Center, New Orleans, LA.
³ Corporal Michael J. Crescenz VA Medical Center & University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
⁴ The University of Texas MD Anderson Cancer Center, Houston, TX.
⁵ Boston Children's Hospital, Harvard Medical School, Boston, MA.
⁶ Mayo Clinic, Rochester, MN.

PMID: 26566064
PMCID: PMC5987259
DOI: 10.1002/hep.28156

No abstract available

PubMed Disclaimer

Conflict of interest statement

Potential conflict of interest: Dr. Jonas consults and received grants from Gilead. She received grants from Bristol-Myers Squibb and Roche. Dr. Chang advises Genentech, Alnylam, and Arbutus. Dr. Terrault consults for Bristol-Myers Squibb and received grants from Gilead. Dr. Bzowej received grants from Gilead, Synageva, and Ocera.

Comment in

AASLD practice guidelines: The past, the present, and the future.
Merriman RB, Tran TT. Merriman RB, et al. Hepatology. 2016 Jan;63(1):31-4. doi: 10.1002/hep.28345. Epub 2015 Dec 8. Hepatology. 2016. PMID: 26565582 No abstract available.

Cited by

Projected epidemiological trends and burden of liver cancer by 2040 based on GBD, CI5plus, and WHO data.
Guo Q, Zhu X, Beeraka NM, Zhao R, Li S, Li F, Mahesh PA, Nikolenko VN, Fan R, Liu J. Guo Q, et al. Sci Rep. 2024 Nov 15;14(1):28131. doi: 10.1038/s41598-024-77658-2. Sci Rep. 2024. PMID: 39548154
Limited stability of Hepatitis B virus RNA in plasma and serum.
Ohlendorf V, Bremer B, Sandmann L, Mix C, Tergast T, Cornberg M, Wedemeyer H, Deterding K, Maasoumy B. Ohlendorf V, et al. Sci Rep. 2024 Nov 7;14(1):27128. doi: 10.1038/s41598-024-77329-2. Sci Rep. 2024. PMID: 39511219 Free PMC article.
Development and validation of a multivariable nomogram predictive of hepatitis B e antigen seroconversion after pregnancy in hepatitis B virus-infected mothers.
Zhong W, Zheng J, Wang C, Shi L, He Y, Zhao Y, Chen T. Zhong W, et al. Front Med (Lausanne). 2024 Oct 21;11:1428569. doi: 10.3389/fmed.2024.1428569. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39497841 Free PMC article.
Monocyte-derived Galectin-9 and PD-L1 differentially impair adaptive and innate immune response in chronic HBV infection and their expression remain unaltered after antiviral therapy.
Dey D, Biswas S, Pal S, Nandi S, Khatun N, Jha R, Chakraborty BC, Baidya A, Ghosh R, Banerjee S, Ahammed SM, Chowdhury A, Datta S. Dey D, et al. Front Immunol. 2024 Oct 9;15:1474853. doi: 10.3389/fimmu.2024.1474853. eCollection 2024. Front Immunol. 2024. PMID: 39445017 Free PMC article.
Postpartum hepatitis flares in mothers with chronic hepatitis B infection.
OuYang S, Geng Y, Qiu G, Deng Y, Deng H, Pan CQ. OuYang S, et al. Gastroenterol Rep (Oxf). 2024 Oct 22;12:goae091. doi: 10.1093/gastro/goae091. eCollection 2024. Gastroenterol Rep (Oxf). 2024. PMID: 39440113 Free PMC article. Review.

See all "Cited by" articles

References

1. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490. - PMC - PubMed
1. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661–662. - PubMed
1. WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva Switzerland: World Health Organization; May 12, 2015. - PubMed
1. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–2219. - PubMed
1. Ioannou GN. Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med. 2011;154:319–28. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

P30 CA016672/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations

[1] Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490. - PMC - PubMed

[2] Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490. - PMC - PubMed

[3] Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661–662. - PubMed

[4] Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661–662. - PubMed

[5] WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva Switzerland: World Health Organization; May 12, 2015. - PubMed

[6] WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva Switzerland: World Health Organization; May 12, 2015. - PubMed

[7] Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–2219. - PubMed

[8] Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–2219. - PubMed

[9] Ioannou GN. Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med. 2011;154:319–28. - PubMed

[10] Ioannou GN. Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med. 2011;154:319–28. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

AASLD guidelines for treatment of chronic hepatitis B

Affiliations

AASLD guidelines for treatment of chronic hepatitis B

Authors

Affiliations

Conflict of interest statement

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Conflict of interest statement

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources